BioLife Solutions, Inc. Standard and Extended Product Warranty Accrual, Decrease for Payments
BioLife Solutions, Inc. (BLFS) reported Standard and Extended Product Warranty Accrual, Decrease for Payments of $825.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-10.
Discontinued › Notes › Product Warranties Disclosures
us-gaap:ProductWarrantyAccrualPayments · last filed 2024-05-10
- BioLife Solutions, Inc. standard and extended product warranty accrual, decrease for payments for the quarter ending 2024-03-31 was $825.00K, a 36.93% decline year-over-year.
- BioLife Solutions, Inc. standard and extended product warranty accrual, decrease for payments for the quarter ending 2023-12-31 was $847.00K, a 60.88% decline year-over-year.
- BioLife Solutions, Inc. standard and extended product warranty accrual, decrease for payments for the quarter ending 2023-09-30 was $922.00K, a 28.59% increase year-over-year.
- BioLife Solutions, Inc. standard and extended product warranty accrual, decrease for payments for the quarter ending 2023-06-30 was $728.00K, a 29.04% decline year-over-year.
- BioLife Solutions, Inc. standard and extended product warranty accrual, decrease for payments for fiscal 2023 was $3.81M, a 31.43% decline from fiscal 2022.
- BioLife Solutions, Inc. standard and extended product warranty accrual, decrease for payments for fiscal 2022 was $5.55M, a 7.62% increase from fiscal 2021.
- BioLife Solutions, Inc. standard and extended product warranty accrual, decrease for payments for fiscal 2021 was $5.16M, a 4344.83% increase from fiscal 2020.
- BioLife Solutions, Inc. standard and extended product warranty accrual, decrease for payments for fiscal 2020 was $116.00K.
| Period end | Standard and Extended Product Warranty Accrual, Decrease for Payments 3 month | Standard and Extended Product Warranty Accrual, Decrease for Payments 3 month as first filed | Standard and Extended Product Warranty Accrual, Decrease for Payments 6 month | Standard and Extended Product Warranty Accrual, Decrease for Payments 6 month as first filed | Standard and Extended Product Warranty Accrual, Decrease for Payments 9 month | Standard and Extended Product Warranty Accrual, Decrease for Payments 9 month as first filed | Standard and Extended Product Warranty Accrual, Decrease for Payments 12 month | Standard and Extended Product Warranty Accrual, Decrease for Payments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | $825.00K 10-Q · filed 2024-05-10 | $1.67M derived: sum of 2 quarters · filed 2024-05-10 | $2.59M derived: sum of 3 quarters · filed 2024-05-10 | $3.32M derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2023-12-31 | $847.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.77M derived: sum of 2 quarters · filed 2024-02-29 | $2.50M derived: sum of 3 quarters · filed 2024-02-29 | $3.81M 10-K · filed 2024-02-29 | ||||
| 2023-09-30 | $922.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.65M derived: sum of 2 quarters · filed 2023-11-09 | $2.96M 10-Q · filed 2023-11-09 | $5.12M derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2023-06-30 | $728.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $2.04M 10-Q · filed 2023-08-09 | $4.20M derived: sum of 3 quarters · filed 2024-05-10 | $4.92M derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2023-03-31 | $1.31M 10-Q · filed 2024-05-10 | $3.47M derived: sum of 2 quarters · filed 2024-05-10 | $4.19M derived: sum of 3 quarters · filed 2024-05-10 | $5.22M derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | $2.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $2.88M derived: sum of 2 quarters · filed 2024-02-29 | $3.91M derived: sum of 3 quarters · filed 2024-02-29 | $5.55M 10-K · filed 2024-02-29 | ||||
| 2022-09-30 | $717.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.74M derived: sum of 2 quarters · filed 2023-11-09 | $3.38M 10-Q · filed 2023-11-09 | $2.80M 10-Q · filed 2022-11-09 | $6.08M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-06-30 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $2.67M 10-Q · filed 2023-08-09 | $2.19M 10-Q · filed 2022-08-09 | $5.36M derived: sum of 3 quarters · filed 2024-02-29 | $7.06M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-03-31 | $1.64M 10-Q · filed 2023-05-11 | $1.12M 10-Q · filed 2022-05-10 | $4.34M derived: sum of 2 quarters · filed 2024-02-29 | $6.04M derived: sum of 3 quarters · filed 2024-02-29 | $6.78M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2021-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $4.39M derived: sum of 2 quarters · filed 2024-02-29 | $5.13M derived: sum of 3 quarters · filed 2024-02-29 | $5.16M 10-K · filed 2024-02-29 | $4.01M 10-K · filed 2022-03-31 | |||
| 2021-09-30 | $1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $2.44M derived: sum of 2 quarters · filed 2022-11-09 | $2.46M 10-Q · filed 2022-11-09 | $2.48M derived: sum of 4 quarters · filed 2023-03-31 | ||||
| 2021-06-30 | $739.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $761.00K 10-Q · filed 2022-08-09 | $785.00K derived: sum of 3 quarters · filed 2023-03-31 | $794.00K derived: sum of 4 quarters · filed 2023-03-31 | ||||
| 2021-03-31 | $22.00K 10-Q · filed 2022-05-10 | $46.00K derived: sum of 2 quarters · filed 2023-03-31 | $55.00K derived: sum of 3 quarters · filed 2023-03-31 | |||||
| 2020-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $33.00K derived: sum of 2 quarters · filed 2023-03-31 | $116.00K 10-K · filed 2023-03-31 | |||||
| 2020-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $92.00K 10-Q · filed 2021-11-15 | ||||||
| 2020-06-30 | $83.00K 10-Q · filed 2021-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |